Kuwait vs Western Pacific (WHO region): Previously treated cases tested for RR-/MDR-TB
Kuwait
100.0%
in 2016
Western Pacific (WHO region)
86.0%
in 2024
Kuwait rank
1st
Western Pacific (WHO region) rank
3rd
Previously treated cases tested for RR-/MDR-TB over time
- Kuwait
- Western Pacific (WHO region)
How they compare
Kuwait currently reports 100.0% against 86.0% in Western Pacific (WHO region), a difference of 14.0%.
That makes Kuwait's figure about 1.2 times Western Pacific (WHO region)'s.
The two have swapped places 2 times across 7 shared years of data; in 2005 it was Kuwait ahead.
Kuwait ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
Kuwait has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kuwait | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 1.2% | 98.8% | Kuwait |
| 2010s | 66.7% | 49.5% | 17.2% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Kuwait or Western Pacific (WHO region)?
- Kuwait, at 100.0% against 86.0% in Western Pacific (WHO region) as of 2016.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Kuwait and Western Pacific (WHO region)?
- 14.0%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Western Pacific (WHO region)?
- 7 years are reported by both, from 2005 to 2016.
- How do Kuwait and Western Pacific (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Kuwait ranks 1st and Western Pacific (WHO region) ranks 3rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.